The Metal Theory of Alzheimer's Disease

被引:258
|
作者
Bush, Ashley I. [1 ]
机构
[1] Univ Melbourne, Mental Hlth Res Inst, Oxidat Biol Lab, Parkville, Vic 3052, Australia
关键词
Alzheimer's disease; amyloid; copper; iron; presenilin; tau; zinc; PLACEBO-CONTROLLED TRIAL; A-BETA; TRANSGENIC MICE; SENILE PLAQUES; DOUBLE-BLIND; IRON-EXPORT; ZINC; COPPER; ACCUMULATION; PBT2;
D O I
10.3233/JAD-2012-129011
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Brain homeostasis of transition metals is severely perturbed in Alzheimer's disease (AD), with extracellular pooling of zinc and copper in amyloid, and intraneuronal accumulation of iron. Rapidly accumulating evidence indicates that these perturbances themselves may contribute significantly to the cognitive loss and neurodegeneration, even in the absence of AD proteopathy. There is now strong evidence that each of the major protein participants in AD pathology has physiologically important interactions with transition metals: A beta PP is the neuronal iron export ferroxidase with a major interaction with ferroportin, presenilins are needed for the import of approximate to 50% of cellular copper and zinc, and tau promotes the export of neuronal iron by facilitating the trafficking of A beta PP to the surface. Therefore, amyloid and tau pathology arise in a milieu of constitutively high metal flux, and the major components of AD pathology may contribute to the disease by failing in their metal transport roles.
引用
收藏
页码:S277 / S281
页数:5
相关论文
共 50 条
  • [21] Rebalancing metal dyshomeostasis for Alzheimer’s disease therapy
    Guan‐Jun Yang
    Hao Liu
    Dik-Lung Ma
    Chung-Hang Leung
    JBIC Journal of Biological Inorganic Chemistry, 2019, 24 : 1159 - 1170
  • [22] Metal chelation as a potential therapy for Alzheimer's disease
    Cuajungco, MP
    Fagét, KY
    Huang, XD
    Tanzi, RE
    Bush, AI
    MOLECULAR BASIS OF DEMENTIA, 2000, 920 : 292 - 304
  • [23] Metal complexing agents as therapies for Alzheimer's disease
    Bush, AI
    NEUROBIOLOGY OF AGING, 2002, 23 (06) : 1031 - 1038
  • [24] Metal dyshomeostasis and oxidative stress in Alzheimer's disease
    Greenough, Mark A.
    Camakaris, James
    Bush, Ashley I.
    NEUROCHEMISTRY INTERNATIONAL, 2013, 62 (05) : 540 - 555
  • [25] Metal and complementary molecular bioimaging in Alzheimer's disease
    Braidy, Nady
    Poljak, Anne
    Marjo, Christopher
    Rutlidge, Helen
    Rich, Anne
    Jayasena, Tharusha
    Inestrosa, Nibaldo C.
    Sachdev, Perminder
    FRONTIERS IN AGING NEUROSCIENCE, 2014, 6
  • [26] Antioxidant Therapy in Alzheimer's Disease: Theory and Practice
    Aliev, Gjumrakch
    Obrenovich, Mark E.
    Reddy, V. Prakash
    Shenk, Justin C.
    Moreira, Paula I.
    Nunomura, Akihiko
    Zhu, Xiongwei
    Smith, Mark A.
    Perry, George
    MINI-REVIEWS IN MEDICINAL CHEMISTRY, 2008, 8 (13) : 1395 - 1406
  • [27] A very incomplete comprehensive theory of Alzheimer's disease
    Davies, P
    ALZEHEIMER'S DISEASE: A COMPENDIUM OF CURRENT THEORIES, 2000, 924 : 8 - 16
  • [28] Determinants of theory of mind performance in Alzheimer's disease
    Ramanan, S.
    de Souza, L. C.
    Sarazin, M.
    Teixeira, A. L.
    Caramelli, P.
    Dubois, B.
    Hornberger, M.
    Bertoux, M.
    JOURNAL OF NEUROCHEMISTRY, 2016, 138 : 268 - 268
  • [29] The Electrophysiological Phenomenon of Alzheimer's Disease: A Psychopathology Theory
    Holston, Ezra C.
    ISSUES IN MENTAL HEALTH NURSING, 2015, 36 (08) : 603 - 613
  • [30] Graph Theory and Brain Connectivity in Alzheimer's Disease
    delEtoile, Jon
    Adeli, Hojjat
    NEUROSCIENTIST, 2017, 23 (06): : 616 - 626